2013-11-12T15:55:51-06:00 2012-12-31 611436956 NOVAK FRANCELLA LLC ONE PRESIDENTIAL BLVD SUITE 330 BALA CYNWYD PA 19004 990 2012-01-01 412161648 INNOVATIONS IN CANCER THERAPY INNO 2023671165 2025 M STREET NW NO 800 WASHINGTON DC 20036 JEANNE MENDELSON 2023671165 2013-11-08 1 LOUIS VERZELLA CPA P00360279 6106689400 2013-11-07 2012 2016-02-24 21:20:13Z JEANNE MENDELSON 2025 M STREET NW NO 800 WASHINGTON DC 20036 696644 0 X WWW.IO-CENTRAL.ORG. X 2005 MA TO ESTABLISH,NURTURE AND SUPPORT INTERVENTIONAL ONCOLOGY AS THE FOURTH PILLAR OF CANCER THERAPY. 9 9 0 0 0 0 0 0 604876 695556 34 0 269 1088 605179 696644 0 0 0 0 0 0 0 0 0 628121 717972 628121 717972 -22942 -21328 261345 225217 21677 6877 239668 218340 TO ESTABLISH,NURTURE AND SUPPORT INTERVENTIONAL ONCOLOGY AS THE FOURTH PILLAR OF CANCER THERAPY. 0 0 ANNUAL MEETING - MULTIDISCIPLINARY SCIENTIFIC MEETING, WITH EXHIBITS, ON INTERVENTIONAL ONCOLOGY ISSUES. THE MEETING PRESENTS CURRENT INFORMATION ON RESEARCH, NEW PRODUCTS, AND NEW TECHNIQUES IN THE INTERVENTIONAL ONCOLOGY FIELD. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 0 0 0 0 0 0 0 0 X 9 9 0 1 0 0 0 0 0 1 1 0 0 1 1 0 0 1 1 0 0 0 X SMITH BUCKLIN & ASSOCIATES INC 2023671164 2025 M STREET SUITE 800 WASHINGTON DC 20036 X MICHAEL C SOULENMD 2.00 X X 0 0 0 GARY S DORFMANMD 1.00 X 0 0 0 RICCARDO A LENCIONIMD 1.00 X 0 0 0 DAVID LUMD 1.00 X 0 0 0 LUIGI SOLBIATIMD 1.00 X 0 0 0 JEFF H GESCHWINDMD 1.00 X 0 0 0 MICHAEL BRUNNERMD 1.00 X 0 0 0 STEPHEN SOLOMONMD 1.00 X 0 0 0 THIERRY DE BAEREMD 1.00 X 0 0 0 MICHELLE ZINNERT 8.00 X 0 0 0 0 0 0 0 0 0 0 SMITHBUCKLIN INC 2025 M STREET NW STE 800 WASHINGTON DC 20036 MANAGEMENT 203888 1 ANNUAL MEETING 900099 675556 675556 CORPORATE PARTNER PROG 900099 20000 20000 695556 MISCELLANEOUS 900099 1088 1088 1088 696644 695556 0 1088 18000 15500 1000 47510 21811 30308 5502 578341 717972 212588 176668 254 13608 48503 34941 261345 225217 1677 1677 20000 5200 21677 6877 X 0 0 0 0 239668 218340 239668 218340 261345 225217 -21328 0 X X 1 X 0 1 0 0 X DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: MANAGEMENT EVALUATED THE ORGANIZATION'S TAX POSITIONS AND CONCLUDED THAT THE ORGANIZATION HAD MAINTAINED ITS TAX EXEMPT STATUS AND HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS. THEREFORE, NO PROVISION OR LIABILITY FOR INCOME TAXES HAS BEEN INCLUDED IN THE FINANCIAL STATEMENTS. AT THE PRESENT TIME, THE ORGANIZATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY U.S. FEDERAL, STATE, OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2009. FORM 990, PART VI, SECTION A, LINE 3 SMITHBUCKLIN MAINTAINS THE BOOKS AND RECORDS OF THE ORGANIZATION AND PERFORMS OTHER MANANGEMENT AND ADMINISTRATIVE FUNCTIONS FOR WHICH IT IS COMPENSATED. FORM 990, PART VI, SECTION B, LINE 11 THE 990 IS REVIEWED BY THE STAFF OF THE MANAGEMENT COMPANY, INCLUDING THE EXECUTIVE DIRECTOR AND A COPY OF THE 990 IS PROVIDED TO THE BOARD PRIOR TO FILING. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICTS OF INTEREST AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQEST AT OFFICE OF THE MANAGEMENT COMPANY. FORM 990, PART XII, LINE 2C: INNOVATIONS IN CANCER THERAPY GOVERNING BODY IS RESPONSIBLE FOR THE FINANCIAL STATEMENT REVIEW AND SELECTION OF THE INDEPENDENT ACCOUNTANT PERFORMING THE REVIEW.